­

About admin

This author has not yet filled in any details.
So far admin has created 70 blog entries.

OncBioMune To Become Exclusive Distributor of Lipomed Drugs in Mexico

BATON ROUGE, LA--(August 10, 2017) - OncBioMune Pharmaceuticals, Inc. (OTCQB: OBMP) ("OncBioMune" or the "Company"), a revenue-stage biopharmaceutical company engaged [...]

OncBioMune Submits Application to Commercialize Anti-Rabies Drug in Mexico

BATON ROUGE, LA--(August 3, 2017) - OncBioMune Pharmaceuticals, Inc. (OTCQB: OBMP) ("OncBioMune" or the "Company"), a revenue-stage biopharmaceutical company engaged [...]

OncBioMune Acquires Propolis Product Line from German Partner

BATON ROUGE, LA--(July 20, 2017) - OncBioMune Pharmaceuticals, Inc. (OTCQB: OBMP) ("OncBioMune" or the "Company"), a revenue-stage biopharmaceutical company engaged [...]

Phase 2 Trial of ProscaVax for Early-Stage Prostate Cancer Nears Commencement

BATON ROUGE, LA--(July 13, 2017) - OncBioMune Pharmaceuticals, Inc. (OTCQB: OBMP) ("OncBioMune" or the "Company"), a revenue-stage biopharmaceutical company engaged [...]

OncBioMune Pharmaceuticals Establishes Another Revenue Stream; Schedules First Patient with AAT Deficiency for Treatment in Mexico

BATON ROUGE, LA--(June 28, 2017) - OncBioMune Pharmaceuticals, Inc. (OTCQB: OBMP) ("OncBioMune" or the "Company"), a revenue-stage biopharmaceutical company engaged [...]

Enrollment to Begin in OncBioMune’s Trial of ProscaVax for Prostate Cancer in Mexico

BATON ROUGE, LA—(June 27, 2017) – OncBioMune Pharmaceuticals, Inc. (OTCQB: OBMP) (“OncBioMune” or the “Company”), a revenue-stage biopharmaceutical company engaged [...]

OncBioMune Receives Patent Protecting Novel Cancer Vaccine in Mexico

BATON ROUGE, LA—(June 21, 2017) - OncBioMune Pharmaceuticals, Inc. (OTCQB: OBMP) ("OncBioMune" or the "Company"), a revenue-stage biopharmaceutical company engaged [...]

OncBioMune Awarded Patent for ProscaVax in Japan

BATON ROUGE, LA--(June 20, 2017) - OncBioMune Pharmaceuticals, Inc. (OTCQB: OBMP) ("OncBioMune" or the "Company"), a revenue-stage biopharmaceutical company engaged [...]

OncBioMune Acquires Norepinefrine for Low Blood Pressure and Heart Failure in Mexico from Teva Pharmaceuticals Mexico

MEXICO CITY, MEXICO--(June 19, 2017) - OncBioMune México, S.A. De C.V., (OTCQB: OBMP) ("OncBioMune" or the "Company"), a revenue-stage biopharmaceutical [...]

OncBioMune, AqVida add additional drugs to distribution agreement (Paclitaxel and Oxaliplatin)

BATON ROUGE, LA--(June 15, 2017) - OncBioMune Pharmaceuticals, Inc. (OTCQB: OBMP) ("OncBioMune" or the "Company"), a clinical stage biopharmaceutical company [...]